Novel Chloride Channel Activator Relieves Symptoms of Irritable Bowel Syndrome: Presented at DDW

Posted by john on May 29th, 2007 — in Celebrex Top News

WASHINGTON, DC — May 28, 2007 — An investigational agent that activates chloride channels, causing increased excretion of fluid into the gastrointestinal tract, significantly improves bowel transit time and relief of constipation in constipation-predominant irritable bowel syndrome (IBS-C).
The agent — lubiprostone — was twice as effective as placebo in relief of IBS-C symptoms in 2 […]

Celebrex Shows Benefits In Premiies

Posted by john on May 25th, 2007 — in Celebrex Top News

ROCHESTER, N.Y., May 17 (UPI) — Celecoxib (Celebrex) prevents the brains of premature babies from bleeding after birth, say doctors at the University of Rochester in New York.
Babies born between 24 and 32 weeks that weigh less than 3.5 pounds have a 20 percent risk of a type of brain bleeding called germinal matrix hemorrhages.
Internet […]

Researcher Lays Out Benefits Of Aspirin To Prevent Colon Cancer

Posted by john on May 25th, 2007 — in Celebrex Top News

A colon cancer researcher at the Ireland Cancer Center of University Hospitals Case Medical Center (UHCMC) has laid out the roadmap for how medical science should employ aspirin and new aspirin-like drugs for use in preventing colon cancer in certain high-risk individuals.
In the New England Journal of Medicine, Sanford Markowitz, MD, PhD, writes an editorial […]

Don’t punish drug’s users for manufacturer’s misdeeds

Posted by john on May 21st, 2007 — in Celebrex Top News

Executives at Purdue Pharma recently agreed to pay $635 million in fines to settle charges they failed to disclose abuse risks of the powerful painkiller OxyContin. They pleaded guilty to “misbranding” the drug.
“Scores died as a result of OxyContin abuse and an even greater number of people became addicted to OxyContin, a drug that Purdue […]

Ivivi PEMF Technology Produces 80% Acceleration in Pain Relief in a Controlled Clinical Study Assessing Post-Surgical Pain

Posted by john on May 21st, 2007 — in Celebrex Top News

Ivivi Technologies, Inc. (AMEX:II), a leader in non-invasive, electrotherapeutic technologies, today announced that preliminary data from a randomized double-blind, placebo-controlled clinical study entitled “Effect of Pulsed Electromagnetic Fields (”PEMF”) on Post-Surgical Pain Reduction for Breast Augmentation” showed an 80% acceleration in pain relief in patients treated with the active technology as compared to patients treated […]

Healing Touch provides relief

Posted by john on May 15th, 2007 — in Celebrex Top News

Ken Corbett will be the first to admit that he was a little skeptical of Healing Touch therapy, at first. So Corbett, a certified Healing Touch practitioner and patient care volunteer at the Hospice Home on Chapel Hill Road, decided to try a little experiment; he chose to monitor three terminally ill patients every day […]

City woman faces 150 charges

Posted by john on May 11th, 2007 — in Celebrex Top News

Register Citizen Staff
BANTAM - A Torrington woman who allegedly posed as a doctor’s assistant to call in prescription drug orders was arraigned in Bantam Superior Court on Thursday on 150 criminal charges.
Police said they caught Marcia L. Beres, a 32-year-old unemployed certified nurse’s assistant who lives at 69 Hyde St., in September attempting to pick […]

Study: How Parents Can Ease Child Immunization

Posted by john on May 8th, 2007 — in Celebrex Top News

A new study suggests parents can ease their child’s anxiety about immunizations by telling a joke, reading a book or bringing a favorite toy from home.
Other proven distraction techniques include blowing soap bubbles and, for babies under six months, using a pacifier dipped in sugar water.
The study’s lead author, Doctor Neil Schechter, directs the Pain […]